EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transcriptomic Signatures of Mitochondrial Dysfunction in Autism: Integrated mRNA and microRNA Profiling

Richard E Frye iD, Zoe Hill, Shannon Rose iD, Sandra McCullough, Patricia A Porter-Gill iD, Pritmohinder S Gill

Genes · 2025

DOI: 10.3390/genes16091065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Richard E Frye und 5 weiteren Autor:innen. Beteiligte Einrichtung: Autism Discovery and Treatment Foundation, Phoenix, AZ 85050, USA. Hauptthemen laut MEDLINE: MicroRNAs, Mitochondria, RNA, Messenger, Transcriptome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research was made possible with funds from Jonty Foundation (St Paul, MN), the XEL Foundation (Pittsburgh, PA) and the Brain Foundation (Pleasanton, CA)., Jonty Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prior work established that about a third of ASD-derived LCLs show excessive mitochondrial respiration and stress vulnerability—features divergent from both controls and classical mitochondrial disease. This study explores how mRNA and microRNA (miRNA) expression profiles distinguish subtypes of autism spectrum disorder (ASD) defined by mitochondrial function.

Methods

Lymphoblastoid cell lines (LCLs) from boys with ASD were classified into two groups: those with abnormal (AD-A) and normal (AD-N) mitochondrial function. RNA-seq compared mRNA and miRNA expression differences.

Results

24 mRNA differentially expressed genes (DEGs) (14 downregulated, 10 upregulated in AD-N vs. AD-A) were identified, implicating processes such as mRNA processing, immune response, cancer biology, and crucially, mitochondrial and nuclear activities. Notably, genes such as DEPTOR (an mTOR modulator) were upregulated in AD-A, highlighting dysregulation in the mTOR pathway—a central regulator of cellular metabolism, protein synthesis, autophagy, and mitochondrial function. miRNA analysis revealed 18 differentially expressed miRNAs (DEMs) upregulated and one downregulated in AD-N compared to AD-A. Several miRNAs (including hsa-miR-1273h-3p, hsa-miR-197-3p, and hsa-miR-199a-5p) targeted both the differentially expressed genes and pathways previously linked to ASD, such as mTOR, Calmodulin Kinase II, and mitochondrial regulation. Enrichment analyses indicated involvement regulation of cell growth and division, gene expression, immune regulation and cellular stress as well as mTOR signaling.

Conclusions

These molecular signatures support the idea that mitochondrial dysfunction in ASD is tied to specific disruptions in the mTOR and PI3K/AKT signaling axes, influencing cell growth, autophagy, oxidative stress handling, and neuronal metabolism. The findings highlight a miRNA-mRNA regulatory network that may underpin mitochondrial dysfunction and ASD heterogeneity, suggesting avenues for subtype-specific biomarkers and targeted therapies that address energy metabolism and cellular stress in ASD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsMitochondriaRNA, MessengerTranscriptomeAutism Spectrum DisorderHumansMaleGene Expression ProfilingChild

Stichwörter der Autor:innen

CamKinase IIautism spectrum disordercell growthmTORmicroRNAmitochondria

Substanzen

MicroRNAsRNA, Messenger

Autor:innen und Institutionen

  • Autism Discovery and Treatment Foundation, Phoenix, AZ 85050, USA.
  • Department of Health Promotion and Disease Prevention, College of Nursing, The University of Tennessee Health Science Center, Memphis, TN 38163, USA.
  • Arkansas Children's Research Institute, Little Rock, AR 72202, USA.
  • Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72202, USA.

ORCID-Profile: Richard E Frye, Shannon Rose, Patricia A Porter-Gill

Förderung

  • This research was made possible with funds from Jonty Foundation (St Paul, MN), the XEL Foundation (Pittsburgh, PA) and the Brain Foundation (Pleasanton, CA).
  • Jonty Foundation

Zitieren

APA

Frye, R. E., Hill, Z., Rose, S., McCullough, S., Porter-Gill, P. A., & Gill, P. S. (2025). Transcriptomic Signatures of Mitochondrial Dysfunction in Autism: Integrated mRNA and microRNA Profiling. Genes. https://doi.org/10.3390/genes16091065

Vancouver

Frye RE, Hill Z, Rose S, McCullough S, Porter-Gill PA, Gill PS. Transcriptomic Signatures of Mitochondrial Dysfunction in Autism: Integrated mRNA and microRNA Profiling. Genes. 2025. doi:10.3390/genes16091065

BibTeX
@article{Frye2025,
  author = {Frye, Richard E and Hill, Zoe and Rose, Shannon and McCullough, Sandra and Porter-Gill, Patricia A and Gill, Pritmohinder S},
  title = {Transcriptomic Signatures of Mitochondrial Dysfunction in Autism: Integrated mRNA and microRNA Profiling},
  journal = {Genes},
  year = {2025},
  doi = {10.3390/genes16091065}
}
Kostenlos starten →